Acute risk for hepatitis E virus infection among HIV-1-positive pregnant women in central Africa

Table 1 Viral status by prevalence of antibodies to hepatitis E virus (HEV) among pregnant women in Gabon, central Africa

Viral status	HEV status	No. (%)	Mean age (years) (SD)	p	Median viral load (copies/ml) [FQ-TQ]	p
HIV-1+	HEV+	13	26.3 (4.5)	NS	1.3E+05 [5.1E+04-9.2E+05]	≤ 0.02
	HEV–	170	28.0 (6.3)	NS	5.7E+04 [1.5E+04-2.4E+05]	≤ 0.02
	Total	13/183 (7.1)	27.9 (6.2)		6.1E+04 [1.5E+04-2.6E+05]
HTLV-1+	HEV+	3	33.7 (5.4)	NS	9.0E+01 [6.0E+00-5.7E+02]	NS
	HEV–	57	28.8 (7.1)	NS	1.1E+03 [2.8E+02-3.9E+03]	NS
	Total	3/60 (5.0)	29.1 (7.1)		9.3E+02 [2.7E+02-3.8E+03]
Total	HEV+	16	27.8 (5.5)	NS	–	-
	HEV–	227	28.2 (6.5)	NS	–	-
	Total	16/243 (6.6)	28.2 (6.5)		–

HEV+: IgG antibodies to HEV in serum; HIV-1, human immunodeficiency virus type 1; HTLV-1, human T-cell leukemia virus type 1; No., number of pregnant women; SD, standard deviation; [FQ–TQ], first quartile–third quartile; NS, not significant; –, not done.
Significance level (p < 0.05) calculated with Student t test for age, Fisher exact test for viral status, and Wilcoxon-Mann–Whitney test for viral load, as the distribution was not normal.

ISSN: 1743-422X